PB-4001

N/A

Report date: 2025/04/11 11:30:45

Base Information

Drug NamePB-4001
Drug Alias NamePB-4001Ceraxa I/O #1
ClassificationSmall molecules
Mechanisms of ActionUndecaprenyl pyrophosphate synthase stimulantsCytotoxic T lymphocytes stimulantsApoptosis inhibitors +[4] 
TargetsUndecaprenyl pyrophosphate synthase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPendreaBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesPendreaBio Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A